Curesign
PrivateLast Round
Seed
Feb 1, 2020
Company Overview
Curesign is a therapeutic devices company that develops medical devices designed to optimize oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Medical AI, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curesign Comparables
Compare Curesign with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoHost | 66% | |
| Adiposs | 59% | |
| VieCure | 57% | |
Curesign Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2020 |
Curesign Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Peregrine Ventures | Seed |
| Nacre Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2020
Raised capital from Nacre Capital and Peregrine Ventures.
Curesign Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curesign's valuation, stock price, and market status.